AIM
EW icon

AIA Investment Management’s Edwards Lifesciences EW Stock Holding History

AIA Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$194K Buy
2,429
+614
+34% +$47.9K 0.04% 171
2020
Q2 		$125K Sell
1,815
-804
-31% -$57.1K 0.03% 146
2020
Q1 		$165K Buy
2,619
+156
+6% +$11.3K 0.03% 110
2019
Q4 		$192K Buy
+2,463
New +$192K 0.24% 65

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIA Investment Management's EW Position: Q3 2020 in Review

AIA Investment Management increased its Edwards Lifesciences (EW) stake by 34% in Q3 2020, buying an estimated $47.9K and bringing the position to 2,429 shares worth $194K. The position accounts for 0.04% of the portfolio, ranked #171.

AIA Investment Management first reported a position in EW in Q4 2019 and has held it in 4 quarters since. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • AIA Investment Management held 2,429 shares of Edwards Lifesciences worth $194K as of Q3 2020.
  • AIA Investment Management bought 614 Edwards Lifesciences shares in Q3 2020, an estimated $47.9K.
  • Edwards Lifesciences made up 0.04% of AIA Investment Management's portfolio in Q3 2020, its #171 holding.
  • AIA Investment Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 4 quarters since.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.